Model 4296 Left Ventricular (LV) Lead Chronic Performance Study
NCT ID: NCT01361672
Last Updated: 2019-07-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1140 participants
OBSERVATIONAL
2011-05-31
2019-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Model 4396 Left Ventricular (LV) Lead Chronic Performance Study
NCT01361685
Model 4196 Left Ventricular (LV) Lead Chronic Performance Study
NCT00930904
Attain Performa™ Left Ventricular (LV) Quadripolar Leads Chronic Performance Study
NCT02294331
Model 4195 Left Ventricular (LV) Lead Chronic Performance Study
NCT00869921
Model 4396 Left Ventricular (LV) Lead Study
NCT00853593
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient has or is intended to receive an Attain Ability Model 4296 LV lead
* Patient within 30 day post implant enrollment window
Exclusion Criteria
* Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Birmingham, Alabama, United States
Anchorage, Alaska, United States
Chandler, Arizona, United States
Gilbert, Arizona, United States
Phoenix, Arizona, United States
Jonesboro, Arkansas, United States
Little Rock, Arkansas, United States
Bakersfield, California, United States
Chula Vista, California, United States
Monterey, California, United States
Rancho Mirage, California, United States
Redding, California, United States
Redwood City, California, United States
Salinas, California, United States
San Diego, California, United States
San Francisco, California, United States
Stanford, California, United States
Torrance, California, United States
Van Nuys, California, United States
Colorado Springs, Colorado, United States
Lakewood, Colorado, United States
New Haven, Connecticut, United States
Newark, Delaware, United States
Washington D.C., District of Columbia, United States
Bradenton, Florida, United States
Clearwater, Florida, United States
Jacksonville, Florida, United States
Melbourne, Florida, United States
Safety Harbor, Florida, United States
Tampa, Florida, United States
Indianapolis, Indiana, United States
West Des Moines, Iowa, United States
Kansas City, Kansas, United States
Lexington, Kentucky, United States
Louisville, Kentucky, United States
Baton Rouge, Louisiana, United States
New Orleans, Louisiana, United States
Hyattsville, Maryland, United States
Silver Spring, Maryland, United States
Takoma Park, Maryland, United States
Worcester, Massachusetts, United States
Lansing, Michigan, United States
Marquette, Michigan, United States
Ypsilanti, Michigan, United States
Robbinsdale, Minnesota, United States
Rochester, Minnesota, United States
Saint Louis Park, Minnesota, United States
Columbia, Missouri, United States
Kansas City, Missouri, United States
St Louis, Missouri, United States
Henderson, Nevada, United States
Las Vegas, Nevada, United States
Lebanon, New Hampshire, United States
Morristown, New Jersey, United States
Ocean City, New Jersey, United States
West Orange, New Jersey, United States
Albuquerque, New Mexico, United States
Garden City, New York, United States
Huntington, New York, United States
New York, New York, United States
Poughkeepsie, New York, United States
Utica, New York, United States
Durham, North Carolina, United States
Greensboro, North Carolina, United States
Winston-Salem, North Carolina, United States
Fargo, North Dakota, United States
Akron, Ohio, United States
Cincinnati, Ohio, United States
Cleveland, Ohio, United States
Toledo, Ohio, United States
Allentown, Pennsylvania, United States
Danville, Pennsylvania, United States
Erie, Pennsylvania, United States
Lancaster, Pennsylvania, United States
Philadelphia, Pennsylvania, United States
Pittsburgh, Pennsylvania, United States
Wilkes-Barre, Pennsylvania, United States
Columbia, South Carolina, United States
Germantown, Tennessee, United States
Kingsport, Tennessee, United States
Nashville, Tennessee, United States
Austin, Texas, United States
Dallas, Texas, United States
Houston, Texas, United States
Plano, Texas, United States
San Antonio, Texas, United States
The Woodlands, Texas, United States
Falls Church, Virginia, United States
Leesburg, Virginia, United States
Olympia, Washington, United States
Spokane, Washington, United States
Tacoma, Washington, United States
Madison, Wisconsin, United States
Milwaukee, Wisconsin, United States
Ottawa, Ontario, Canada
Peterborough, Ontario, Canada
Montreal, Quebec, Canada
Québec, Quebec, Canada
Essen, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
4296 Chronic Performance
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.